Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 11 (4) , 281-289
- https://doi.org/10.1053/srao.2001.26027
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Epidermal growth factor.Published by Elsevier ,2021
- Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitorInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Induction of the Angiogenic Modulator Fibroblast Growth Factor-binding Protein by Epidermal Growth Factor Is Mediated through Both MEK/ERK and p38 Signal Transduction PathwaysJournal of Biological Chemistry, 2000
- Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJournal of Clinical Oncology, 2000
- Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and RadiationCancer Biotherapy & Radiopharmaceuticals, 1999
- Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical ResultsInvestigational New Drugs, 1999
- Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian CellsJournal of Biological Chemistry, 1998
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell Biology, 1994
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.Journal of Biological Chemistry, 1984